Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
LOXAPAC IM SANDOZ CANADA INCORPORATED Anticipated shortage 50MG New Report 2024-04-30 226623
HYDRALAZINE HYDROCHLORIDE INJECTION, USP AURO PHARMA INC Actual shortage 20MG Updated Report 2024-04-30 221285
PLERIXAFOR INJECTION JAMP PHARMA CORPORATION Actual shortage 20MG Updated Report 2024-04-30 223974
!!T3 ORENCIA BRISTOL-MYERS SQUIBB CANADA Actual shortage 125MG Updated Report 2024-04-30 222656
XYLAC PENDOPHARM DIVISION OF PHARMASCIENCE INC Actual shortage 10MG Updated Report 2024-04-30 226445
TRANEXAMIC ACID INJECTION AURO PHARMA INC Resolved 100MG Updated Report 2024-04-30 216024
SURVANTA ABBVIE CORPORATION Actual shortage 25MG Updated Report 2024-04-30 226027
NAT-MONTELUKAST NATCO PHARMA (CANADA) INC Actual shortage 4MG Updated Report 2024-04-30 226579
NAT-MONTELUKAST NATCO PHARMA (CANADA) INC Actual shortage 5MG Updated Report 2024-04-30 226582
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Actual shortage 150MG Updated Report 2024-04-30 226594

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
ISENTRESS MERCK CANADA INC To be discontinued 25MG Updated Report 2024-04-29 204164
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-04-29 204160
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 5MG New Report 2024-04-26 226355
DELATESTRYL BAUSCH HEALTH, CANADA INC. Discontinued 200MG Updated Report 2024-04-26 221772
STRATTERA ELI LILLY CANADA INC Discontinued 18MG Updated Report 2024-04-24 171480